← Back to Search

Brachial artery ultrasound imaging for Cardiovascular Disease

N/A
Waitlist Available
Research Sponsored by Everist Genomics, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Summary

The objective of the study is to define the analytical repeatability of quantifying flow-mediated dilation of the brachial artery using brachial artery ultrasound imaging using upper arm cuff occlusion.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline % flow-mediated dilation (%FMD) at 1 hour
Secondary outcome measures
Incidence of emergent adverse device effects (ADEs) according to CTCAE v4.03

Trial Design

1Treatment groups
Experimental Treatment
Group I: Brachial artery ultrasound imagingExperimental Treatment1 Intervention
Brachial artery ultrasound imaging is a non-invasive procedure for detecting endothelial dysfunction by measuring the flow-mediated dilation of the brachial artery using high resolution continuous electrocardiogram-gated B-mode (2D) ultrasound imaging during reactive hyperemia.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Brachial artery ultrasound imaging
2016
N/A
~30

Find a Location

Who is running the clinical trial?

Everist Genomics, IncLead Sponsor
2 Previous Clinical Trials
191 Total Patients Enrolled
Peter F Lenehan, MD PhDStudy ChairEverist Health
2 Previous Clinical Trials
191 Total Patients Enrolled
~2 spots leftby Sep 2025